Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists

被引:32
作者
Böhme, TM
Keim, C
Kreutzmann, K
Linder, M
Dingermann, T
Dannhardt, G
Mutschler, E
Lambrecht, G
机构
[1] Johannes Gutenberg Univ Mainz, Inst Pharm, D-55099 Mainz, Germany
[2] Goethe Univ Frankfurt, Dept Pharmacol & Pharmaceut Biol, Bioctr Niederursel, D-60439 Frankfurt, Germany
关键词
D O I
10.1021/jm020895l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 2,3-disubstituted indenes, which are analogues of the widely used histamine H, receptor antagonist dimethindene, have been synthesized and studied as muscarinic and histamine receptor antagonists. The affinities of these compounds for the five human muscarinic receptor subtypes (M-1-M-5) and for human histamine H, receptors were determined in radioligand binding studies using membranes from transfected Chinese hamster ovary (CHO) cells and [H-3]N-methylscopolamine ([H-3]NMS). The results demonstrate that the diisopropyl analogue 19 has a similar high affinity as (S)-dimethindene at M-2 receptors ((S)-dimethindene: pK(i) = 7.52; (-)-19: pK(i) = 7.37) with an improved selectivity pattern ((S)-dimethindene: M-2/M-1 = 6-fold, M-2/M-3 = 5-fold, M-2/M-4 = 10-fold, M-2/M-5 = 25-fold; (-)-19: M-2/M-1 = 36-fold, M-2/M-3 = 96-fold, M-2/M-4 = 42-fold, M-2/M-5 = 275-fold). In addition, compound (-)-19 showed 35-fold lower affinity at histamine H-1 receptors (pK(i) = 5.61) than (S)-dimethindene (pK(i) = 7.16). Another interesting compound is the fluoroethyl derivative 20 (pK(i)/M-2 = 7.49), which also exhibits a higher M-2 selectivity (M-2/M-1 = 19-fold; M-2/M-3 = 22-fold; M-2/M-4 = 13-fold; M-2/ M-5 = 62-fold) than (S)-dimethindene. Unfortunately, compound 20 also shows a high affinity for histamine H-1 receptors (pK(i) = 8.14). The compound with the highest affinity for M-2 receptors (pK(i) = 7.91), the dimethylaminomethylene analogue 31, displayed only a small preference for M-2 receptors. In conclusion, compound (-)-19 might be useful to test the hypothesis that blockade of muscarinic M-2 receptors in the brain is a viable mechanism by which to produce improved cognition. This second-generation dimethindene analogue might also be the starting point for the development Of M-2-selective muscarinic antagonists useful for quantifying M-2 receptors in the central nervous system with positron emission tomography imaging.
引用
收藏
页码:856 / 867
页数:12
相关论文
共 32 条
[1]   Identification and characterization of m4 selective muscarinic antagonists [J].
Augelli-Szafran, CE ;
Jaen, JC ;
Moreland, DW ;
Nelson, CB ;
Penvose-Yi, JR ;
Schwarz, RD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (15) :1991-1996
[2]  
Baghdoyan HA, 1998, J PHARMACOL EXP THER, V286, P1446
[3]  
BUCKLEY NJ, 1989, MOL PHARMACOL, V35, P469
[4]   SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals [J].
Carey, GJ ;
Billard, W ;
Binch, H ;
Cohen-Williams, M ;
Crosby, G ;
Grzelak, M ;
Guzik, H ;
Kozlowski, JA ;
Lowe, DB ;
Pond, AJ ;
Tedesco, RP ;
Watkins, RW ;
Coffin, VL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 431 (02) :189-200
[5]   STEREOCHEMICAL STUDIES OF CHIRAL H-1 ANTAGONISTS OF HISTAMINE - THE RESOLUTION, CHIRAL ANALYSIS, AND BIOLOGICAL EVALUATION OF 4 ANTIPODAL PAIRS [J].
CASY, AF ;
DRAKE, AF ;
GANELLIN, CR ;
MERCER, AD ;
UPTON, C .
CHIRALITY, 1992, 4 (06) :356-366
[6]   MUSCARINIC RECEPTORS - CHARACTERIZATION, COUPLING AND FUNCTION [J].
CAULFIELD, MP .
PHARMACOLOGY & THERAPEUTICS, 1993, 58 (03) :319-379
[7]  
Caulfield MP, 1998, PHARMACOL REV, V50, P279
[8]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[9]  
CICUREL L, 1992, AGENTS ACTIONS, pC440
[10]   In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones [J].
Cohen, VI ;
Jin, BY ;
McRee, RC ;
Boulay, SF ;
Cohen, EI ;
Sood, VK ;
Zeeberg, BR ;
Reba, RC .
BRAIN RESEARCH, 2000, 861 (02) :305-315